Serum albumin: a pharmacokinetic marker for optimizing treatment outcome of immune checkpoint blockade
Crossref DOI link: https://doi.org/10.1136/jitc-2022-005670
Published Online: 2022-12-20
Published Print: 2022-12
Update policy: https://doi.org/10.1136/crossmarkpolicy
Zheng, Ming https://orcid.org/0000-0002-3651-7701
Funding for this research was provided by:
National Natural Science Foundation of China (32100739)
License valid from 2022-12-20